Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 151 AL 165

What Do Recent Clinical Trials Teach Us About the Etiology of AD

Robakis NK.

Adv Exp Med Biol. 2020;1195:167. doi: 10.1007/978-3-030-32633-3_23.

Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease

Popugaeva E, Chernyuk D, Bezprozvanny I.

Curr Alzheimer Res. 2020;17(4):344-354. doi: 10.2174/1567205017666200528162046.

Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

Meng L, Li XY, Shen L, Ji HF.

Trends Mol Med. 2020 Jun;26(6):597-614. doi: 10.1016/j.molmed.2020.02.002. Epub 2020 Mar 23.

Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease

Wilson B, Geetha KM.

J Control Release. 2020 Sep 10;325:25-37. doi: 10.1016/j.jconrel.2020.05.044. Epub 2020 May 28.

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

Mamun AA, Uddin MS, Bin Bashar MF, Zaman S, Begum Y, Bulbul IJ, Islam MS, Sarwar MS, Mathew B, Amran MS, Md Ashraf G, Bin-Jumah MN, Mousa SA, Abdel-Daim MM.

Oxid Med Cell Longev. 2020 May 15;2020:5086250. doi: 10.1155/2020/5086250. eCollection 2020.

Translational Scoring of Candidate Treatments for Alzheimer's Disease: A Systematic Approach

Cummings JL.

Dement Geriatr Cogn Disord. 2020;49(1):22-37. doi: 10.1159/000507569. Epub 2020 Jun 8.

The Nerve to Give BACE Inhibitors a Second Chance?

Baloh RH.

Neurotherapeutics. 2020 Jul;17(3):966-967. doi: 10.1007/s13311-020-00876-9.

Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential

Sousa JCE, Santana ACF, MagalhÃes GJP.

Arq Neuropsiquiatr. 2020 Jun 8;78(8):501-511. doi: 10.1590/0004-282X20200010.

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease

Cacabelos R.

Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):673-701. doi: 10.1080/17425255.2020.1779700. Epub 2020 Jun 23.

Takotsubo Cardiomyopathy in an Alzheimer Disease Patient: The Potential Contribution of Antidepressant Agents

Moulin Mares SRA, Groner JS, de Oliveira MP, Lírio LV, Coutinho PC, Luchi WM.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):360-361. doi: 10.1097/WAD.0000000000000395.

Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia

Wang S, Temkin-Greener H, Conwell Y, Cai S.

J Am Med Dir Assoc. 2020 Nov;21(11):1617-1622.e3. doi: 10.1016/j.jamda.2020.04.005. Epub 2020 Jun 9.

Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential

Ding XW, Li R, Geetha T, Tao YX, Babu JR.

Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165858. doi: 10.1016/j.bbadis.2020.165858. Epub 2020 Jun 10.

Crosstalk between obesity, diabetes, and alzheimer's disease: Introducing quercetin as an effective triple herbal medicine

Ebrahimpour S, Zakeri M, Esmaeili A.

Ageing Res Rev. 2020 Sep;62:101095. doi: 10.1016/j.arr.2020.101095. Epub 2020 Jun 11.

Role of antioxidants and a nutrient rich diet in Alzheimer's disease

Veurink G, Perry G, Singh SK.

Open Biol. 2020 Jun;10(6):200084. doi: 10.1098/rsob.200084. Epub 2020 Jun 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias